Medical Tests (29)

Diagnostic Testing (11)

Note:

Some component of this panel might be part of the comprehensive metabolic panel.


Note:

Rule out cancer of islet cells.


Note:

EGFR is expressed 30-50% in Pancreatic ductal adenocarcinoma (PDAC). http://www.ncbi.nlm.nih.gov/pubmed/26361407


Note:

Not specific for pancreas cancer, but helpful in therapy treatment.

Other Supportive/Alternative Tests (8)

Note:

Determine therapeutic strategy for cancer therapeutics such as Tegafur.


Note:

Alternative to specif gene markers. Good for therapy selection and monitoring.


Note:

Individual cancer test tissue specific is recommended.

ICD10

C25Malignant neoplasm of pancreas
C25.0Malignant neoplasm of head of pancreas
C25.1Malignant neoplasm of body of pancreas
C25.2Malignant neoplasm of tail of pancreas
C25.7Malignant neoplasm of other parts of pancreas
C25.9Malignant neoplasm of pancreas, unspecified
Z85Personal history of malignant neoplasm
Z85.07Personal history of malignant neoplasm of pancreas

SNOMED

372003004Primary malignant neoplasm of pancreas